IRIS
SFRAMELI, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.431
NA - Nord America 4.153
AS - Asia 2.187
SA - Sud America 782
Continente sconosciuto - Info sul continente non disponibili 205
AF - Africa 66
OC - Oceania 2
Totale 11.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.998
RU - Federazione Russa 2.328
SG - Singapore 831
CN - Cina 676
BR - Brasile 675
IE - Irlanda 521
IT - Italia 347
PL - Polonia 305
SE - Svezia 301
HK - Hong Kong 217
DE - Germania 155
FR - Francia 151
VN - Vietnam 140
GB - Regno Unito 111
FI - Finlandia 92
IN - India 87
CA - Canada 48
MX - Messico 44
AR - Argentina 35
BD - Bangladesh 35
TR - Turchia 29
NL - Olanda 23
ZA - Sudafrica 20
IQ - Iraq 19
AT - Austria 17
BE - Belgio 16
EC - Ecuador 16
VE - Venezuela 16
ID - Indonesia 15
JP - Giappone 15
UA - Ucraina 15
UZ - Uzbekistan 15
PK - Pakistan 14
MA - Marocco 13
CO - Colombia 12
CR - Costa Rica 11
IL - Israele 11
ES - Italia 9
JM - Giamaica 9
JO - Giordania 9
NI - Nicaragua 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
KE - Kenya 8
NP - Nepal 8
SA - Arabia Saudita 8
CI - Costa d'Avorio 7
EU - Europa 7
HN - Honduras 7
LT - Lituania 7
PH - Filippine 7
MY - Malesia 6
SV - El Salvador 6
GT - Guatemala 5
KZ - Kazakistan 5
OM - Oman 5
PR - Porto Rico 5
PY - Paraguay 5
SC - Seychelles 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
CL - Cile 4
CW - ???statistics.table.value.countryCode.CW??? 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
EG - Egitto 3
HU - Ungheria 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CY - Cipro 2
DZ - Algeria 2
GE - Georgia 2
GP - Guadalupe 2
GY - Guiana 2
HR - Croazia 2
KR - Corea 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AM - Armenia 1
BM - Bermuda 1
BW - Botswana 1
CH - Svizzera 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 11.627
Salva come PNG Salva come JPEG
Città #
Ashburn 704
Moscow 634
Dublin 520
Singapore 454
Chandler 416
Dallas 298
Warsaw 296
Beijing 274
San Jose 264
Hong Kong 217
Nyköping 195
Council Bluffs 147
The Dalles 121
Princeton 103
Los Angeles 82
Lauterbourg 75
Jacksonville 74
Ann Arbor 73
Medford 72
Munich 68
Messina 61
Cambridge 56
Des Moines 46
Ho Chi Minh City 44
São Paulo 43
Pune 42
Buffalo 39
Bremen 37
Lancaster 35
Tianjin 35
Boardman 34
Rome 34
Turku 34
New York 33
Redondo Beach 31
Dearborn 30
Santa Clara 30
Houston 28
Atlanta 25
Hanoi 25
Shenyang 25
San Mateo 24
Frankfurt am Main 22
Rio de Janeiro 22
Belo Horizonte 21
Jinan 21
Wilmington 20
Orem 19
Nanjing 17
Brussels 16
Guangzhou 16
Brasília 15
Dong Ket 15
Hebei 15
Porto Alegre 15
Tashkent 15
Tokyo 15
Chennai 14
North Bergen 14
Shanghai 14
Phoenix 13
Poplar 13
Curitiba 12
Mexico City 12
Ningbo 12
Seattle 12
Chicago 11
Hangzhou 11
Johannesburg 11
Montreal 11
Amsterdam 10
Baghdad 10
Brooklyn 10
Campinas 10
Amman 9
Ankara 9
Denver 9
Guadalupe 9
Haikou 9
Jakarta 9
Managua 9
San Francisco 9
Stockholm 9
Taizhou 9
Toronto 9
Vienna 9
Charlotte 8
Falls Church 8
Nuremberg 8
San José 8
Zhengzhou 8
Abidjan 7
Boston 7
Cagliari 7
Catania 7
Helsinki 7
Manchester 7
Milan 7
Nairobi 7
Palo Del Colle 7
Totale 6.553
Salva come PNG Salva come JPEG
Nome #
Clinical and molecular characterization of patients affected by congenital muscular dystrophies using next generation sequencing strategies 290
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 252
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 245
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 240
Nusinersen versus sham control in later-onset spinal muscular atrophy 213
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 209
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 208
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 208
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 204
Effect of exercise on telomere length and telomere proteins expression in mdx mice 202
Autonomic nervous system involvement in spinal muscular atrophy. 197
An observational study of functional abilities in infants, children, and adults with type 1 SMA 192
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 191
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 190
Pilot study of flavocoxid in ambulant DMD patients. 182
Pilot study of serial casting in muscular dystrophy patients. 180
Pilot study of serial casting of ankles in muscular dystrophy patients. 177
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 177
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 176
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 175
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 174
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 170
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 168
Psychosocial impact of sport activity in neuromuscular disorders 166
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 166
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 164
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 162
Pilot study of flavocoxid in ambulant DMD patients. 162
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 161
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy 160
Pilot study of flavocoxid in ambulant DMD patients. 159
Severe rhabdomyolysis in a patient with “Heat Stroke” 159
The 24-month PUL changes and steroids correlation. 159
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 159
Clinical variability in spinal muscular atrophy type III 155
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 153
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 153
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 152
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 152
Development of an academic disease registry for spinal muscular atrophy 151
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with Duchenne muscular dystrophy: a skeckle tracking study. 149
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies in the UK and differences with the Italian population 147
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 144
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 143
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 142
study of flavocoxid in ambulant DMD patients. 139
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 135
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 135
Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of Congenital Muscular Dystrophies: Analysis of the UK diagnostic service 2001-2013. 132
Pilot study of flavocoxid in ambulant DMD patients. 130
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 128
Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey? 128
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys 127
Congenital myastenic syndromes due a novel GFPT1 mutation: a new Italian case 123
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 123
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 121
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies 119
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study 111
Pilot study of flavocoxid in ambulant DMD patients. 108
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 104
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 103
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 103
Old measures and new scores in spinal muscular atrophy patients 93
The respiratory symptom check-list for patients with myotonic dystrophies: preliminary results. 93
Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function 93
“I have got something positive out of this situation”: Psychological benefits of caregiving in relatives of young people with muscular dystrophy 90
Stato dell'arte sulle terapie della Distrofia muscolare di Duchenne. 89
Neuropsychiatric comorbidities in Duchenne Muscular Dystrophy. 87
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired 86
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 85
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 84
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. 81
The families of children with muscular dystrophies: burden, social network and professional support. 78
Sleep disorders in spinal muscular atrophy 77
The genetic spectrum of a large cohort of putative CMD. 75
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy 75
Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen 74
The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure 70
Screening for early symptoms of respiratory involvement in myotonic dystrophy type 1 using the Respicheck questionnaire 69
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 66
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life Inventory TM neuromuscular Module in the Italian population and correlation with other functional assessments. 64
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 34
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function 32
null 27
null 22
null 20
null 20
null 18
null 15
Neurofilaments as Biomarkers of Disease Activity and Treatment Response in Spinal Muscular Atrophy 2
Totale 11.826
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 0 0 24 4 44 18 8 54 39 215
2022/20231.432 98 146 69 105 129 122 10 70 638 9 29 7
2023/2024367 17 61 18 52 22 96 31 15 0 6 5 44
2024/20251.776 39 35 38 109 57 51 65 369 400 130 182 301
2025/20265.304 270 328 353 371 452 1.076 635 689 707 242 88 93
2026/20271.094 119 374 193 352 56 0 0 0 0 0 0 0
Totale 11.826